New opportunities of dual bronchodilation therapy for patients with chronic obstructive pulmonary disease

New opportunities of dual bronchodilation therapy for patients with chronic obstructive pulmonary disease

Currently, combinations of long-acting beta2-agonists and long-acting anticholinergics are considered as the basic therapy for majority of patients with chronic obstructive pulmonary disease (COPD). These combinations have different pharmacological characteristics and delivery devices that provides...

Full description

Bibliographic Details
Main Authors:	S N Avdeev, N V Trushenko
Format:	Article
Language:	Russian
Published:	"Consilium Medicum" Publishing house 2019-03-01
Series:	Терапевтический архив
Subjects:	chronic obstructive pulmonary disease dual bronchodilation therapy aclidinium/formoterol combination
Online Access:	https://ter-arkhiv.ru/0040-3660/article/viewFile/33018/pdf

Similar Items

12-Hour fixed-dose combination of andrenergic agonist and cholinergic antagonist in a new administration device: analytical review
by: A. A. Vizel, et al.
Published: (2018-10-01)

A Real-World Study on the Day and Night-Time Symptoms Among Greek COPD Patients Who Recently Initiated Treatment with Dual Bronchodilation: The DANICO Study
by: Kostikas K, et al.
Published: (2022-09-01)

Specific role of combination aclidinium: formoterol in the treatment of chronic obstructive pulmonary disease
by: Matera MG, et al.
Published: (2016-01-01)

Efficacy of aclidinium/formoterol 400/12 µg, analyzed by airflow obstruction severity, age, sex, and exacerbation history: pooled analysis of ACLIFORM and AUGMENT
by: D'Urzo AD, et al.
Published: (2019-02-01)

Comparison of Effectiveness Using Different Dual Bronchodilator Agents in Chronic Obstructive Pulmonary Disease Treatment
by: Shih-Lung Cheng
Published: (2021-06-01)

Modern possibilities of correction of broncho-obstructive syndrome in chronic heart failure of ischemic origin in combination with chronic obstructive pulmonary disease: simple randomized parallel group study
by: Vladimir V. Evdokimov, et al.
Published: (2023-06-01)

Dual Bronchodilator in the Era of Triple Therapy
by: Papaioannou AI, et al.
Published: (2020-10-01)

The Pharmacokinetics, Safety and Tolerability of Aclidinium Bromide 400 μg Administered by Inhalation as Single and Multiple (Twice Daily) Doses in Healthy Chinese Participants
by: Li W, et al.
Published: (2023-11-01)

Clinical experience of using formoterol/budesonide in patients with chronic obstructive pulmonary disease
by: I. V. Demko, et al.
Published: (2021-10-01)

Global initiative gold and national recommendations on the management of patients with chronic obstructive pulmonary disease (COPD): the place of double bronchodilation
by: A. A. Vizel, et al.
Published: (2019-12-01)

The efficacy of aclidinium/formoterol on lung function and symptoms in patients with COPD categorized by symptom status: a pooled analysis
by: Miravitlles M, et al.
Published: (2016-08-01)

Bronchodilator reversibility test for broncho-obstructive syndrome detection and differential diagnosis of bronchial asthma and chronic obstructive pulmonary disease
by: V. P. Melnyk, et al.
Published: (2019-04-01)

Is it possible to modify the course of chronic obstructive pulmonary disease with modern medication?
by: S N Avdeev
Published: (2008-08-01)

ACTIVATE: the effect of aclidinium/formoterol on hyperinflation, exercise capacity, and physical activity in patients with COPD
by: Watz H, et al.
Published: (2017-08-01)

Formoterol for the Treatment of Chronic Obstructive Pulmonary Disease
by: Tashkin DP
Published: (2020-11-01)

When is dual bronchodilation indicated in COPD?
by: Thomas M, et al.
Published: (2017-08-01)

Short-acting bronchodilators for the management of acute exacerbations of chronic obstructive pulmonary disease in the hospital setting: systematic review
by: Zoe A. Kopsaftis, et al.
Published: (2018-11-01)

The double bronchodilation era: new capabilities in a new drug delivery device
by: E. A. Orlova, et al.
Published: (2022-04-01)

Clinical experience of using double bronchodilation therapy in patients with COPD
by: I. V. Demko, et al.
Published: (2019-12-01)

INFLOW study: a prospective observational study for assessment of indacaterol and other bronchodilators in symptomatic chronic obstructive pulmonary disease patients from Egypt
by: Waleed M. El-Sorougi, et al.
Published: (2017-01-01)

Newer therapeutic options in chronic obstructive pulmonary disease
by: Jesin Kumar Chakkamadathil
Published: (2023-01-01)

Pharmacological therapy for stable chronic obstructive pulmonary disease
by: Ruirui Duan, et al.
Published: (2023-06-01)

A Real-World Observational Study Examining the Impact of Aclidinium Bromide Therapy on the Quality of Life, Symptoms, and Activity Impairment of Patients with Chronic Obstructive Pulmonary Disease: The Greek ON-AIR Study
by: Kostikas K, et al.
Published: (2020-03-01)

Shared Decision-Making Facilitates Inhaler Choice in Patients with Newly-Diagnosed Chronic Obstructive Pulmonary Disease: A Multicenter Prospective Study
by: Hsiao YH, et al.
Published: (2022-09-01)

Comparative studies of dual bronchodilation in COPD
by: Mario Cazzola, et al.
Published: (2021-02-01)

An Indian perspective on the use of fluticasone/formoterol in asthma and chronic obstructive pulmonary disease patients
by: Rahul Sharma, et al.
Published: (2021-01-01)

Effect of Bronchodilator and Steroid Use on Heart Disease and Stroke Risks in a Bronchiectasis–Chronic Obstructive Pulmonary Disease Overlap Cohort: A Propensity Score Matching Study
by: Jun-Jun Yeh, et al.
Published: (2019-11-01)

Small Airways, Big Problem: Extrafine beclomethasone/formoterol in asthma and chronic obstructive pulmonary disease
by: Ashfaq Hasan, et al.
Published: (2021-01-01)

Predictors of asthma-chronic obstructive pulmonary disease overlap syndrome in patients with chronic obstructive pulmonary disease from a tertiary care center in India
by: Irfan Ismail Ayub, et al.
Published: (2018-01-01)

Bronchodilator treatment of stable COPD: long-acting anticholinergics
by: W. Vincken
Published: (2005-09-01)

Prevention of copd exacerbations. Focus on dual bronchodilators
by: V. V. Arkhipov
Published: (2018-10-01)

Comparison of Rapid Bronchodilatory Effects of Salmeterol and Formoterol in Patients with Moderate to Severe Asthma
by: Ebrahim Salehifar, et al.
Published: (2015-10-01)

Pharmacotherapy of chronic obstructive pulmonary disease: Therapeutic considerations with a focus on inhaled corticosteroids
by: Elvis M. Irusen, et al.
Published: (2020-12-01)

AMPLIFY: a randomized, Phase III study evaluating the efficacy and safety of aclidinium/formoterol vs monocomponents and tiotropium in patients with moderate-to-very severe symptomatic COPD
by: Sethi S, et al.
Published: (2019-03-01)

Comparative Efficacy of Budesonide/Formoterol Versus Fluticasone/Salmeterol in Patients With Moderate-to-Severe Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis
by: Nan Shang, et al.
Published: (2024-12-01)

Chronic obstructive pulmonary disease – A neglected and underestimated chronic lung disease in India: A large single-center study in India
by: Shital Patil, et al.
Published: (2023-01-01)

Spirometric Indices after Bronchodilator Test in Obstructive Lung Disease
by: Amir Houshang Mehrparvar, et al.
Published: (2010-08-01)

Spirometric Indices after Bronchodilator Test in Obstructive Lung Disease
by: Amir Houshang Mehrparvar, et al.
Published: (2010-07-01)

Major comorbidities lead to the risk of adverse cardiovascular events in chronic obstructive pulmonary disease patients using inhaled long-acting bronchodilators: a case-control study
by: Yen-Fu Chen, et al.
Published: (2019-12-01)

Beyond Dual Bronchodilation – Triple Therapy, When and Why
by: Cazzola M, et al.
Published: (2022-01-01)